Fior Markets launched a study titled “Global Autoimmune Treatment Market by Product and Service (Consumables and Assay Kits, Instruments, Services), Test Type, End User (Clinical Laboratories, Hospitals, Others), Region” and Global Forecast 2018-2025.
The global autoimmune treatment market is expected to grow from USD 3.28 Billion in 2017 to USD 7.95 Billion by 2025 at a CAGR of 11.68% during the forecast period from 2018-2025. Availability of biosimilars and generic drugs for the treatment of the autoimmune diseases and government policies to restrict prevalence of autoimmune disease will lead to the growth of market in a couple of years.
DOWNLOAD FREE SAMPLE REPORT:https://www.fiormarkets.com/report-detail/362217/request-sample
The consumables and assay kits segment based segment is anticipated to grow with the highest CAGR of 13.08% over the forecast period
Product and service segment includes consumables and assay kits, instruments and services. The consumables and assay kits segment based segment is anticipated to grow with the highest CAGR of 13.08% over the forecast period. Increasing initiatives by pharmaceutical companies to develop innovative products and these are the key factors to drive the demand of the segment.
Autoantibodies and immunologic tests segment held the largest market share of 33.61% in 2017
Test type segment is divided into segments such as routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests and other tests. Autoantibodies and immunologic tests based segment held the largest market share of 33.61% in 2017. Disease specific kits, therapy & monitoring are the key factors will lead to the growth of the segment in future.
Rheumatoid arthritis segment was valued around USD 1.32 billion in 2017
Disease segment is divided into segments such as rheumatoid arthritis, systemic lupus erythematosus, sjögren’s syndrome, thyroiditis, scleroderma and other diseases. Rheumatoid arthritis dominated the market and was valued around USD 1.32 billion in 2017. Rising prevalence of this disease and growing patient awareness levels are major factors for the market growth.
Hospital segment is expected to grow with the highest CAGR of 14.39% in the forecast period
End user segment is divided into segments such as includes clinical laboratories, hospitals and other end users. The hospital segment is expected to grow with the highest CAGR of 14.39% in the forecast period.
Regional Segmentation Analysis:
The market is analysed on the basis of five regions namely North America, Europe, Asia Pacific, South America, and Middle East and Africa. North America held the largest market share of approximately 38.21% in 2017. Presences of large patient base suffering from various autoimmune disorders has led to the growth of market in this region.
The major players of market include Abbott Laboratories, Trinity Biotech, Bio-rad Laboratories, F. Hoffmann-la Roche, Inova Diagnostics, Inc., Euroimmun AG, Biomérieux, Siemens Healthineers, Inc., Myriad Genetics, Thermo Fisher Scientific, Amgen, Johnson & Johnson, Eli Lilly & Co., Pfizer, Roche, Astrazeneca Plc and others.
Customization of the Report:
This report can be customized to meet the client’s requirements. Please connect with our sales team (firstname.lastname@example.org), who will ensure that you get a report that suits your needs.